• 1. Aggregation-induced chiroptical generation and photoinduced switching of achiral azobenzene-alt-fluorene copolymer endowed with left- and right-handed helical polysilanes?
  Hailing Chen,Lu Yin,Meng Liu,Laibing Wang,Michiya Fujiki,Wei Zhang RSC Adv., 2019,9, 4849-4856
• 2. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 3. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
• 4. An ion-exchange method for determining paraquat residues in food crops
  Analyst, 1965,90, 99-106
• 5. Aluminium coordination complexes in copolymerization reactions of carbon dioxide and epoxides
  Nduka Ikpo,Jenna C. Flogeras,Francesca M. Kerton Dalton Trans., 2013,42, 8998-9006

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Organooxygen compounds
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds

Recent Advances in the Application of Dipentyl Phosphonate (CAS 1809-17-2) in Chemical Biology and Pharmaceutical Research

Dipentyl phosphonate (CAS 1809-17-2) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its versatile applications as a key intermediate in organic synthesis and its potential biological activities. This research brief aims to synthesize the latest findings on the compound, highlighting its synthesis methodologies, mechanistic insights, and emerging applications in drug discovery and development.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the efficacy of dipentyl phosphonate as a precursor in the synthesis of novel phosphonate-based prodrugs targeting resistant bacterial strains. The researchers utilized a modified Kabachnik-Fields reaction to incorporate dipentyl phosphonate into antimicrobial agents, resulting in compounds with enhanced membrane permeability and sustained release profiles. Notably, these derivatives exhibited 4-8 fold greater potency against methicillin-resistant Staphylococcus aureus (MRSA) compared to conventional phosphonate drugs.

Recent advancements in analytical techniques have enabled more precise characterization of dipentyl phosphonate's physicochemical properties. Nuclear magnetic resonance (NMR) and mass spectrometry analyses conducted by the European Chemical Biology Institute revealed unexpected stability of the compound in physiological conditions, with a hydrolysis half-life of 72 hours at pH 7.4. This finding, published in ChemBioChem (2024), suggests potential for extended in vivo activity when used in pharmaceutical formulations.

In cancer research, dipentyl phosphonate has emerged as a promising scaffold for developing targeted therapies. A multi-center study led by the National Cancer Institute demonstrated that dipentyl phosphonate derivatives could selectively inhibit histone deacetylase (HDAC) isoforms, particularly HDAC6, with IC50 values in the low micromolar range. The research, published in Cancer Research (2024), showed that these compounds induced significant apoptosis in triple-negative breast cancer cell lines while sparing normal mammary epithelial cells.

The compound's application has also expanded to materials science, with a recent breakthrough in drug delivery systems. Researchers at MIT developed a dipentyl phosphonate-functionalized polymer that self-assembles into pH-responsive nanoparticles. This innovation, detailed in Advanced Materials (2023), demonstrated superior loading capacity (up to 28% w/w) for hydrophobic anticancer drugs and triggered release specifically in tumor microenvironments.

Despite these promising developments, challenges remain in the large-scale production and purification of dipentyl phosphonate. A 2024 review in Organic Process Research & Development highlighted the need for more sustainable synthetic routes, as current methods often require hazardous reagents and generate substantial waste. Several pharmaceutical companies have initiated green chemistry programs to address these limitations, with preliminary results showing potential for biocatalytic approaches using engineered phosphatases.

Looking forward, the unique properties of dipentyl phosphonate position it as a valuable tool in chemical biology and a promising candidate for further pharmaceutical development. Ongoing clinical trials with dipentyl phosphonate-derived compounds are expected to report preliminary results in 2025, which may validate its therapeutic potential in various disease areas. The compound's versatility continues to inspire innovative applications across multiple disciplines within the chemical and biological sciences.

• 1809-14-9(Phosphonic acid,dioctyl ester)
• 17026-85-6(1-Hexadecanol,1-(dihydrogen phosphate), potassium salt (1:?))
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)